Trial
NCT00311246
Trial of Adalimumab in Progressive Sarcoidosis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
Abbott
Condition
Sarcoidosis
Intervention
Adalimumab
Why stopped
Difficulty in recruiting subjects
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-08-25